Overall survival for patients with melanoma that has spread to the brain is only four to six months. Immunotherapies, which harness the power of the immune system to attack cancer cells, have garnered excitement in recent ...
May 31, 2023
0
26
Gene alterations in biliary tract cancer offer potential targets for current or future precision therapies. This is demonstrated by a study conducted by Karl Landsteiner University of Health Sciences in collaboration with ...
May 31, 2023
0
23
Since it was identified in 1984 as the cause of Acquired Immune Deficiency Syndrome (AIDS), the human immunodeficiency virus (HIV) has infected more than 80 million people and been responsible for some 40 million deaths worldwide, ...
May 30, 2023
0
32
A scientific team from the University of Barcelona and the CIBERobn has designed a strategy to fight obesity and diabetes in mice through ex vivo gene therapy which consists of implanting cells that have been manipulated ...
May 30, 2023
0
3
Newcastle and Hunter-based researchers have discovered a drug combination that could improve the life expectancy of children with brain cancer.
May 30, 2023
0
71
A new distributional cost-effectiveness analysis of gene therapy versus standard-of-care for sickle cell disease (SCD) found that while gene therapy is cost-ineffective by conventional measures, it can be an equitable therapeutic ...
May 29, 2023
0
4
Thanks to the radiation they emit, radioactive compounds are suited both to imaging and treating cancers. By appropriately combining them in novel, so-called radionuclide theranostics, both applications can be dovetailed. ...
May 26, 2023
0
51
Hydrogen sulfide is usually a highly toxic gas. However, with careful preparation, it can be used to support photothermal therapy (PTT) in treating cancer, as a team of researchers reporting in the journal Angewandte Chemie ...
May 26, 2023
0
42
Up to 60% of cancer patients receive radiation therapy, but it doesn't always work. Failure of these treatments results from tumor regrowth at the primary tumor site, or when the tumor metastasizes to another part of the ...
May 25, 2023
0
57
A new research perspective titled "HER3- A key survival pathway and an emerging therapeutic target in metastatic colorectal cancer and pancreatic ductal adenocarcinoma" has been published in Oncotarget.
May 24, 2023
0
0
